Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
archive
fda
boston blog main
boston top stories
clinical trials
drugs
life sciences
medical
medicine
national blog main
national top stories
new york blog main
new york top stories
san diego blog main
san diego top stories
akcea therapeutics
alder biopharmaceutical
allergan
american academy of neurology
amgen
anylam pharmaceuticals
atogepant
biohaven
biotech
bob azelby
botox
boulder/denver blog main
boulder/denver top stories
brian abrahams
calcitonin gene-related peptide
cardiomyopathy
detroit blog main
detroit top stories
eli lilly
eptinezumab
erenumab
fremanezumab
galcanezumab
government
healthcare
What
drug
6
×
fda
6
×
year
6
×
medication
approved
cancer
months
popular
recalls
risk
warning
administration
agency's
ago
akcea
alnylam
amyloidosis
announcement
approval
arguments
attr
available
away
battle
big
binding
bit
blood
broadcast
called
caused
class
commercialized
companies
competitors
debilitating
decades
depression
described
device
Language
unset
Current search:
drug
×
year
×
fda
×
@slashgear.com
3 years ago
Popular diabetes drug recalled months after FDA issued cancer risk warning
@slashgear.com
4 years ago
Another popular heartburn drug gets FDA cancer warning
@slashgear.com
5 years ago
This nasal spray stops med-resistant depression in trials
@xconomy.com
5 years ago
FDA OKs Pfizer Rare Disease Drug, Sets Up Battle With Alnylam, Akcea
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@theverge.com
8 years ago
The FDA doesn’t want to regulate wearables, and device makers want to keep it that way